Crossref
Effect of certepetide (LSTA‐1) on immune system engagement against pancreatic ductal adenocarcinoma (PDAC): An iLSTA sub‐study
Asia-Pacific Journal of Clinical Oncology · 2026-11 · 22 (S6) · 15-15
DOI: 10.1111/ajco.70230 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, online erschienen am 19.11.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Effect of certepetide (LSTA‐1) on immune system engagement against pancreatic ductal adenocarcinoma (PDAC): An iLSTA sub‐study. Asia-Pacific Journal of Clinical Oncology, 22(S6), 15-15. https://doi.org/10.1111/ajco.70230
Vancouver
Effect of certepetide (LSTA‐1) on immune system engagement against pancreatic ductal adenocarcinoma (PDAC): An iLSTA sub‐study. Asia-Pacific Journal of Clinical Oncology. 2026;22(S6):15-15. doi:10.1111/ajco.70230
BibTeX
@article{euvimed2026,
title = {Effect of certepetide (LSTA‐1) on immune system engagement against pancreatic ductal adenocarcinoma (PDAC): An iLSTA sub‐study},
journal = {Asia-Pacific Journal of Clinical Oncology},
year = {2026},
volume = {22},
number = {S6},
pages = {15--15},
doi = {10.1111/ajco.70230}
}
EUVIMED